Respiratory syncytial virus immune globulin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRespiratory syncytial virus immune globulin
Drug Alias NameRespiratory syncytial virus immune globulin intravenousๅ‘ผๅธ้“ๅˆ่ƒžไฝ“็—…ๆฏ’ๅ…็–ซ็ƒ่›‹็™ฝHypermune RSVRSV immunoglobulinRespiGam +[6]ย 
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionRespiratory syncytial virus F protein inhibitors
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsRespiratory Syncytial Virus Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/01/01
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB
Related LinksN/A